Tadalafil Lilly

Maa: Euroopan unioni

Kieli: englanti

Lähde: EMA (European Medicines Agency)

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
21-09-2023
Valmisteyhteenveto Valmisteyhteenveto (SPC)
21-09-2023

Aktiivinen ainesosa:

tadalafil

Saatavilla:

Eli Lilly Nederland B.V.

ATC-koodi:

G04BE08

INN (Kansainvälinen yleisnimi):

tadalafil

Terapeuttinen ryhmä:

Urologicals

Terapeuttinen alue:

Erectile Dysfunction

Käyttöaiheet:

Treatment of erectile dysfunction in adult males.In order for tadalafil to be effective, sexual stimulation is required.Tadalafil Lilly is not indicated for use by women.Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.

Tuoteyhteenveto:

Revision: 6

Valtuutuksen tilan:

Authorised

Valtuutus päivämäärä:

2017-03-22

Pakkausseloste

                                61
B. PACKAGE LEAFLET
62
PACKAGE LEAFLET: INFORMATION FOR THE USER
TADALAFIL LILLY 2.5 MG FILM-COATED TABLETS
tadalafil
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Tadalafil Lilly is and what it is used for
2.
What you need to know before you take Tadalafil Lilly
3.
How to take Tadalafil Lilly
4.
Possible side effects
5
How to store Tadalafil Lilly
6.
Contents of the pack and other information
1.
WHAT TADALAFIL LILLY IS AND WHAT IT IS USED FOR
Tadalafil Lilly is a treatment for adult men with erectile
dysfunction. This is when a man cannot get,
or keep a hard, erect penis suitable for sexual activity. Tadalafil
Lilly has been shown to significantly
improve the ability of obtaining a hard erect penis suitable for
sexual activity.
Tadalafil Lilly contains the active substance tadalafil which belongs
to a group of medicines called
phosphodiesterase type 5 inhibitors. Following sexual stimulation
Tadalafil Lilly works by helping the
blood vessels in your penis to relax, allowing the flow of blood into
your penis. The result of this is
improved erectile function. Tadalafil Lilly will not help you if you
do not have erectile dysfunction.
It is important to note that Tadalafil Lilly does not work if there is
no sexual stimulation. You and your
partner will need to engage in foreplay, just as you would if you were
not taking a medicine for
erectile dysfunction.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE TADALAFIL LILLY
DO NOT TAKE TADALAFIL LILLY IF YOU:
-
are allergic to tadalafil or any of the othe
                                
                                Lue koko asiakirja
                                
                            

Valmisteyhteenveto

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Tadalafil Lilly 2.5 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
Each tablet contains 2.5 mg tadalafil.
Excipient with known effect
Each coated tablet contains 87 mg of lactose (as monohydrate).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet).
Light orange-yellow and almond shaped tablets of 8.58 mm by 5.23 mm,
marked "C 2 ½" on one side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective, sexual stimulation is
required.
Tadalafil Lilly is not indicated for use by women.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adult men _
In general, the recommended dose is 10 mg taken prior to anticipated
sexual activity and with or
without food.
In those patients in whom tadalafil 10 mg does not produce an adequate
effect, 20 mg might be tried. It
may be taken at least 30 minutes prior to sexual activity.
The maximum dose frequency is once per day.
Tadalafil 10 and 20 mg is intended for use prior to anticipated sexual
activity and it is not
recommended for continuous daily use.
In patients who anticipate a frequent use of Tadalafil Lilly (i.e., at
least twice weekly) a once daily
regimen with the lowest doses of Tadalafil Lilly might be considered
suitable, based on patient choice
and the physician’s judgement.
In these patients the recommended dose is 5 mg taken once a day at
approximately the same time of
day. The dose may be decreased to 2.5 mg once a day based on
individual tolerability.
The appropriateness of continued use of the daily regimen should be
reassessed periodically.
3
_Special populations _
_Elderly men _
Dose adjustments are not required in elderly patients.
_Men with renal impairment _
Dose adjustments are not required in patients with mild to moderate
renal impairment. For patients
with severe renal impairment 10 mg is the maximum recommended dose.

                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste bulgaria 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto bulgaria 21-09-2023
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta bulgaria 07-04-2017
Pakkausseloste Pakkausseloste espanja 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto espanja 21-09-2023
Pakkausseloste Pakkausseloste tšekki 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto tšekki 21-09-2023
Pakkausseloste Pakkausseloste tanska 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto tanska 21-09-2023
Pakkausseloste Pakkausseloste saksa 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto saksa 21-09-2023
Pakkausseloste Pakkausseloste viro 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto viro 21-09-2023
Pakkausseloste Pakkausseloste kreikka 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto kreikka 21-09-2023
Pakkausseloste Pakkausseloste ranska 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto ranska 21-09-2023
Pakkausseloste Pakkausseloste italia 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto italia 21-09-2023
Pakkausseloste Pakkausseloste latvia 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto latvia 21-09-2023
Pakkausseloste Pakkausseloste liettua 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto liettua 21-09-2023
Pakkausseloste Pakkausseloste unkari 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto unkari 21-09-2023
Pakkausseloste Pakkausseloste malta 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto malta 21-09-2023
Pakkausseloste Pakkausseloste hollanti 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto hollanti 21-09-2023
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta hollanti 07-04-2017
Pakkausseloste Pakkausseloste puola 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto puola 21-09-2023
Pakkausseloste Pakkausseloste portugali 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto portugali 21-09-2023
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta portugali 07-04-2017
Pakkausseloste Pakkausseloste romania 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto romania 21-09-2023
Pakkausseloste Pakkausseloste slovakki 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto slovakki 21-09-2023
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta slovakki 07-04-2017
Pakkausseloste Pakkausseloste sloveeni 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto sloveeni 21-09-2023
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta sloveeni 07-04-2017
Pakkausseloste Pakkausseloste suomi 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto suomi 21-09-2023
Pakkausseloste Pakkausseloste ruotsi 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto ruotsi 21-09-2023
Pakkausseloste Pakkausseloste norja 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto norja 21-09-2023
Pakkausseloste Pakkausseloste islanti 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto islanti 21-09-2023
Pakkausseloste Pakkausseloste kroatia 21-09-2023
Valmisteyhteenveto Valmisteyhteenveto kroatia 21-09-2023

Etsi tähän tuotteeseen liittyviä ilmoituksia

Näytä asiakirjojen historia